Ameritas Advisory Services LLC Grows Stock Holdings in Procter & Gamble Company (The) $PG

Ameritas Advisory Services LLC boosted its position in Procter & Gamble Company (The) (NYSE:PGFree Report) by 77.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 38,732 shares of the company’s stock after acquiring an additional 16,901 shares during the period. Ameritas Advisory Services LLC’s holdings in Procter & Gamble were worth $5,551,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Maseco LLP purchased a new stake in Procter & Gamble in the 4th quarter worth approximately $28,000. Saranac Partners Ltd purchased a new stake in shares of Procter & Gamble during the 3rd quarter valued at $30,000. Caitlin John LLC purchased a new stake in shares of Procter & Gamble during the 3rd quarter valued at $34,000. Anfield Capital Management LLC grew its stake in shares of Procter & Gamble by 121.5% during the 4th quarter. Anfield Capital Management LLC now owns 237 shares of the company’s stock valued at $34,000 after buying an additional 130 shares during the period. Finally, Legacy Wealth Managment LLC ID grew its stake in shares of Procter & Gamble by 162.6% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 239 shares of the company’s stock valued at $34,000 after buying an additional 148 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Up 0.4%

Shares of Procter & Gamble stock opened at $143.94 on Wednesday. The company has a fifty day moving average price of $147.20 and a 200 day moving average price of $148.40. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.44. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $170.99. The stock has a market cap of $335.18 billion, a price-to-earnings ratio of 21.04, a price-to-earnings-growth ratio of 6.15 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The firm had revenue of $21.24 billion during the quarter, compared to analysts’ expectations of $21.52 billion. During the same period in the prior year, the company earned $1.54 EPS. The firm’s revenue was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 24th will be given a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Friday, April 24th. This is an increase from Procter & Gamble’s previous quarterly dividend of $1.06. Procter & Gamble’s dividend payout ratio is currently 63.60%.

Insider Buying and Selling

In other Procter & Gamble news, CEO Gary A. Coombe sold 36,093 shares of the company’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $162.33, for a total value of $5,858,976.69. Following the completion of the transaction, the chief executive officer directly owned 34,994 shares of the company’s stock, valued at $5,680,576.02. This represents a 50.77% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Susan Street Whaley sold 1,809 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $159.46, for a total transaction of $288,463.14. Following the completion of the transaction, the insider directly owned 30,215 shares of the company’s stock, valued at approximately $4,818,083.90. The trade was a 5.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 220,852 shares of company stock worth $35,880,848 over the last quarter. Company insiders own 0.20% of the company’s stock.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Procter & Gamble was highlighted as a high-quality dividend stock and a defensive business selling everyday necessities, which can appeal to investors looking for stability in a volatile market.
  • Positive Sentiment: Analysts noted that PG still has broad-based global growth and that its U.S. Baby Care weakness appears fixable rather than a structural problem, suggesting the brand portfolio remains resilient.
  • Neutral Sentiment: PG is attracting increased investor interest and search activity, signaling that traders are actively reassessing the stock after recent weakness.
  • Neutral Sentiment: A broader market discussion flagged consumer staples like PG as a pressured sector when inflation stays elevated and consumers trade down to cheaper alternatives.
  • Negative Sentiment: Rising plastic costs tied to higher oil prices could squeeze input margins for consumer packaged goods companies, including PG, if they cannot fully pass along higher costs.
  • Negative Sentiment: Recent articles emphasized that PG has fallen in recent months as inflation and margin concerns continue to weigh on sentiment, which may be limiting near-term upside.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on PG shares. Royal Bank Of Canada lowered their price objective on shares of Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating for the company in a research note on Thursday, April 9th. Piper Sandler lifted their price objective on Procter & Gamble from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Friday, April 24th. BNP Paribas Exane reduced their price objective on Procter & Gamble from $172.00 to $165.00 and set an “outperform” rating on the stock in a research note on Thursday, April 23rd. The Goldman Sachs Group reduced their price objective on Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 8th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $163.00 price objective on shares of Procter & Gamble in a research note on Monday, April 27th. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $161.06.

Read Our Latest Stock Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.